trial · primary record
ST-503
Chronic Neuropathic Pain
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 27 |
| Primary completion | 2028-07 |
| Primary endpoint | Incidence and severity of treatment emergent adverse events (TEAEs) |
| Registry ID | NCT06980948 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:45.999Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06980948
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.